Agency Information Collection Activities; Proposed Collection; Comment Request; Semi-Annual and Final Reporting Requirements for the Older Americans Act Title IV Discretionary Grant Program, 16309-16310 [E6-4696]
Download as PDF
<![CDATA[
dsatterwhite on PROD1PC76 with NOTICES
Federal Register / Vol. 71, No. 62 / Friday, March 31, 2006 / Notices
Hague, N., Zhang, X., & Broxmeyer, H.E.
‘‘Interferon-inducible Protein 10 and
Macrophage Inflammatory Protein-1 a
Inhibit Growth Factor Stimulation of
Raf-1 Kinase Activity and Protein
Synthesis in a Human Growth Factordependent Hematopoietic Cell Line.’’
JBC 270:21998–22007, 1995 (September
15) (‘‘JBC paper’’).
• Figures 1 (both panels), 3A, 3B, 3D,
3E, 4A, and 8A in: Aronica, S.M.,
Gingras, A.C., Sonenberg, N., Cooper, S.,
Hague, N., & Broxmeyer, H.E.
‘‘Macrophage Inflammatory Protein-1 a
and Interferon-inducible Protein 10
Inhibit Synergistically Induced Growth
Factor Stimulation of MAP Kinase
Activity and Suppress Phosphorylation
of Eukaryotic Initiation Factor 4E and
4E Binding Protein 1.’’ Blood 89:3582–
3595, 1997 (May 15) (‘‘Blood paper’’).
• Figures 1B and 2B in: Aronica,
S.M., Reid, S.L., & Broxmeyer, H.E.
‘‘Chemokine Inhibition of StressActivated Kinase Activity in a Human
Hematopoietic Cell Line.’’ Blood,
submitted August 4, 1997 (‘‘Blood
manuscript’’).
The research was supported by or
reported in the following U.S. Public
Health Service (PHS) grants from the
National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK)
and the National Heart, Lung, and Blood
Institute (NHLBI) of the National
Institutes of Health:
• RO1 HL49202, ‘‘Myeloid Regulation
by Growth-Suppressing Cytokines.’’
• R01 HL54037, ‘‘Stem Cell
Transduction of SLF/FLT–3–Ligand
Genes by AAV.’’
• R01 HL56416, ‘‘Mechanisms of
Synergistic Regulation of Stem/
Progenitors.’’
• T32 DK07519, ‘‘Regulation of
Hematopoietic Cell Production.’’
The following administrative actions
have been implemented:
(1) Dr. Aronica has been debarred
from any contracting or subcontracting
with any agency of the United States
Government and from eligibility or
involvement in nonprocurement
programs of the United States
Government referred to as ‘‘covered
transactions’’ as defined in the
debarment regulations at 45 CFR part 76
for a period of five (5) years, beginning
on February 10, 2006;
(2) Dr. Aronica is prohibited from
serving in any advisory capacity to PHS
including but not limited to service on
any PHS advisory committee, board,
and/or peer review committee, or as
consultant for a period of five (5) years,
beginning on February 10, 2006; and
(3) Within 60 days of February 10,
2006, the authors of the following
papers will be requested to submit a
VerDate Aug<31>2005
16:35 Mar 30, 2006
Jkt 208001
letter to the editors of Journal of
Biological Chemistry and Blood,
requesting their retraction of:
• Aronica, S.M., Mantel, C., Gonin,
R., Marshall, M., Sarris, A., Cooper, S.,
Hague, N., Zhang, X-f., & Broxmeyer,
H.E. ‘‘Interferon-Inducible Protein 10
and Macrophage Inflammatory Protein1 a inhibit Growth Factor Stimulation of
Raf–1 Kinase Activity and Protein
Synthesis in a Human Growth FactorDependent Hematopoietic Cell Line.’’ J.
Biol. Chem. 270:21998–22007, 1995.
• Aronica, S.M., Gingras, A.-C.,
Sonenberg, N., Cooper, S., Hague, N.,
and Broxmeyer, H.E. ‘‘Macrophage
Inflammatory Protein–1 a and
Interferon-Inducible Protein 10 Inhibit
Synergistically Induced Growth Factor
Stimulation of MAP Kinase Activity and
Suppress Phosphorylation of Eukaryotic
Initiation Factor 4E and 4# Binding
Protein 1.’’ Blood 89:3582–3595, 1997.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852. (240) 453–8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E6–4688 Filed 3–30–06; 8:45 am]
BILLING CODE 4160–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration on Aging
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Semi-Annual and
Final Reporting Requirements for the
Older Americans Act Title IV
Discretionary Grant Program
Administration on Aging, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: The Administration on Aging
(AoA) is announcing an opportunity for
public comment on the proposed
collection of certain information by the
agency. Under the Paperwork Reduction
Act of 1995 (the PRA), Federal agencies
are required to publish notice in the
Federal Register concerning each
proposed collection of Information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection requirements relating to
Performance Progress Reports for Title
IV grantees.
DATES: Submit written or electronic
comments on the collection of
information by May 30, 2006.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
16309
Submit electronic
comments on the collection of
information to: greg.case@aoa.hhs.gov.
Submit written comments on the
collection of information to Greg Case,
Administration on Aging, Washington,
DC 20201 or by fax to (202) 357–3469.
FOR FURTHER INFORMATION CONTACT: Greg
Case at (202) 357–3442 or
greg.case@aoa.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, AoA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following collection
of information, AoA invites comments
on: (1) Whether the proposed collection
of information is necessary for the
proper performance of AoA’s functions,
including whether the information will
have practical utility; (2) the accuracy of
AoA’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
when appropriate, and other forms of
information technology.
AoA plans to submit to the Office of
Management and Budget for approval
Guidelines for Preparing Performance
Reports for Grants Supported by Title IV
of the Older Americans Act. These
guidelines provide instructions for
semi-annual and final performance
reporting pursuant to requirements in
Title IV of the Older Americans Act.
Through its Title IV Program, the
Administration on Aging (AoA)
supports projects for the purpose of
developing and testing new knowledge
and program innovations with the
potential for contributing to the wellADDRESSES:
E:\FR\FM\31MRN1.SGM
31MRN1
16310
Federal Register / Vol. 71, No. 62 / Friday, March 31, 2006 / Notices
being of older Americans. Deliverables
required by the AoA of all Title IV
grantees are the semi-annual and final
reports, as provided for in Department
of Health and Human Services
regulations, 45 CFR Part 74, Section
74.51. The proposed guidelines may be
found on the Administration on Aging
Web site at https://www.aoa.gov/
doingbus/grantrep/grantrep.asp.
AoA estimates the burden of this
collection of information as follows:
Semi-annual submission with the final
report taking the place of the semiannual report at the end of the final year
of the grant. Respondents: States, public
agencies, private nonprofit agencies,
institutions of higher education, and
organizations including tribal
organizations. Estimated Number of
Responses: 600. Total Estimated Burden
Hours: 12,000.
Dated: March 28, 2006.
Josefina G. Carbonell,
Assistant Secretary for Aging.
[FR Doc. E6–4696 Filed 3–30–06; 8:45 am]
Announcements PA–04–038, PA–04–021,
PA–04–030, and PAR–04–105.
For Further Information Contact:
Charles N. Rafferty, PhD, Designated
Federal Official, National Institute for
Occupational Safety and Health, CDC,
1600 Clifton Road, NE., Mailstop E–74,
Atlanta, GA 30333; Telephone Number
404.498.2582. The Director,
Management Analysis and Services
Office, has been delegated the authority
to sign Federal Register notices
pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: March 27, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–4708 Filed 3–30–06; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Member
Conflict: Safety and Occupational
Health, Program Announcements PA–
04–038, PA–04–021, PA–04–030, and
PAR–04–105
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 6777, dated
February 9, 2006) is amended to reflect
the reorganization of the Division of
Birth Defects and Developmental
Disabilities, within the National Center
on Birth Defects and Developmental
Disabilities.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the mission statement for the
Division of Birth Defects and
Developmental Disabilities (CUBB),
insert the following:
Office of the Director (CUBB1). (1)
Manages, directs, and coordinates the
research agenda and activities of the
division; (2) provides leadership and
guidance on strategic planning, policy,
program and project priority planning
and setting, program management, and
operations; (3) establishes division
goals, objectives, and priorities; (4)
monitors progress in implementation of
projects and achievement of objectives;
(5) plans, allocates, and monitors
dsatterwhite on PROD1PC76 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Member Conflict: Safety and
Occupational Health, Program
Announcements PA–04–038, PA–04–021,
PA–04–030, and PAR–04–105.
Time and Date: 2 p.m.–5 p.m., April 20,
2006 (Closed).
Place: National Institute for Occupational
Safety and Health, CDC, 24 Executive Park
Drive NE, MS E–74, Room 1429, Atlanta, GA
30329; Telephone Number 404.498.2582.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to: Member Conflict: Safety and
Occupational Health, Program
VerDate Aug<31>2005
18:41 Mar 30, 2006
Jkt 208001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
resources; (6) provides management,
administrative, and support services,
and coordinates with appropriate
NCBDDD offices on program and
administrative matters; (7) provides
liaison with other CDC organizations,
other governmental agencies,
international organizations, and other
outside groups; (8) provides support for
internal scientific advisory groups; (9)
provides scientific leadership and
guidance to the division to assure
highest scientific quality and
professional standards; and (10)
provides coordinative support for CDC’s
efforts to reduce adverse consequences
from birth defects, developmental
disabilities, and pediatric genetic
conditions.
Birth Defects Branch (CUBBB). (1)
Designs and conducts epidemiologic
and genetic research to identify causes
and risk factors of birth defects; (2)
conducts evaluates interventions to
improve infant and child health by
preventing or reducing the adverse
consequences of birth defects; (3)
designs and conducts surveillance of
selected birth defects to identify rates,
trends, and patterns of occurrence, and
to evaluate the effectiveness of
prevention programs; (4) disseminates
findings of studies to the scientific and
public health communities, and to the
general public; (5) provides technical
assistance to state and local agencies on
surveillance of birth defects,
epidemiologic research, prevention
program design and evaluation, and
prevention effectiveness research; (6)
funds and coordinates grant and
cooperative agreement programs and
other extramural activities to improve
the knowledge base for the prevention
of birth defects through surveillance,
epidemiologic research, and applies
research of preventive interventions; (7)
coordinates activities with other CDC
functional units, HHS, other federal
agencies,and appropriate private
organizations regarding research and
prevention programs for birth defects;
(8) works with international
organizations in developing strategies
for the prevention of birth defects; and
(9) disseminates findings of research
through direct contact with health
authorities, publication and distribution
of special reports, publication in
scientific and technical journals,
conference presentations, and other
appropriate means.
Prevention Research Branch (CUBBC).
(1) Modifies the impact of prenatal
exposures leading to adverse physical
and developmental impairments in
infants, children, and adults including
integrating successful prevention
programs into social and medical
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 71, Number 62 (Friday, March 31, 2006)]
[Notices]
[Pages 16309-16310]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4696]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration on Aging
Agency Information Collection Activities; Proposed Collection;
Comment Request; Semi-Annual and Final Reporting Requirements for the
Older Americans Act Title IV Discretionary Grant Program
AGENCY: Administration on Aging, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Administration on Aging (AoA) is announcing an opportunity
for public comment on the proposed collection of certain information by
the agency. Under the Paperwork Reduction Act of 1995 (the PRA),
Federal agencies are required to publish notice in the Federal Register
concerning each proposed collection of Information, including each
proposed extension of an existing collection of information, and to
allow 60 days for public comment in response to the notice. This notice
solicits comments on the information collection requirements relating
to Performance Progress Reports for Title IV grantees.
DATES: Submit written or electronic comments on the collection of
information by May 30, 2006.
ADDRESSES: Submit electronic comments on the collection of information
to: greg.case@aoa.hhs.gov. Submit written comments on the collection of
information to Greg Case, Administration on Aging, Washington, DC 20201
or by fax to (202) 357-3469.
FOR FURTHER INFORMATION CONTACT: Greg Case at (202) 357-3442 or
greg.case@aoa.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, AoA is publishing notice of the proposed collection
of information set forth in this document. With respect to the
following collection of information, AoA invites comments on: (1)
Whether the proposed collection of information is necessary for the
proper performance of AoA's functions, including whether the
information will have practical utility; (2) the accuracy of AoA's
estimate of the burden of the proposed collection of information,
including the validity of the methodology and assumptions used; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques when appropriate, and other forms of information
technology.
AoA plans to submit to the Office of Management and Budget for
approval Guidelines for Preparing Performance Reports for Grants
Supported by Title IV of the Older Americans Act. These guidelines
provide instructions for semi-annual and final performance reporting
pursuant to requirements in Title IV of the Older Americans Act.
Through its Title IV Program, the Administration on Aging (AoA)
supports projects for the purpose of developing and testing new
knowledge and program innovations with the potential for contributing
to the well-
[[Page 16310]]
being of older Americans. Deliverables required by the AoA of all Title
IV grantees are the semi-annual and final reports, as provided for in
Department of Health and Human Services regulations, 45 CFR Part 74,
Section 74.51. The proposed guidelines may be found on the
Administration on Aging Web site at https://www.aoa.gov/doingbus/
grantrep/grantrep.asp.
AoA estimates the burden of this collection of information as
follows: Semi-annual submission with the final report taking the place
of the semi-annual report at the end of the final year of the grant.
Respondents: States, public agencies, private nonprofit agencies,
institutions of higher education, and organizations including tribal
organizations. Estimated Number of Responses: 600. Total Estimated
Burden Hours: 12,000.
Dated: March 28, 2006.
Josefina G. Carbonell,
Assistant Secretary for Aging.
[FR Doc. E6-4696 Filed 3-30-06; 8:45 am]
BILLING CODE 4154-01-P
